Therapeutic Anticoagulation Delays Death in COVID-19 Patients: Cross-Sectional Analysis of a Prospective Cohort

A hypercoagulable state has been described in coronavirus disease 2019 (COVID-19) patients. Others have reported a survival advantage with prophylactic anticoagulation (pAC) and therapeutic anticoagulation (tAC), but these retrospective analyses have important limitations such as confounding by indi...

Descripción completa

Detalles Bibliográficos
Autores principales: Ionescu, Filip, Grasso-Knight, Giovi, Castillo, Edward, Naeem, Ehsun, Petrescu, Ioana, Imam, Zaid, Patel, Vishal K., Narasimhan, Mangala, Nair, Girish B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Georg Thieme Verlag KG 2020
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7519875/
https://www.ncbi.nlm.nih.gov/pubmed/32995704
http://dx.doi.org/10.1055/s-0040-1716721

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7519875/
https://www.ncbi.nlm.nih.gov/pubmed/32995704
http://dx.doi.org/10.1055/s-0040-1716721

Ejemplares similares